ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 274 filers reported holding ARRAY BIOPHARMA INC in Q1 2019. The put-call ratio across all filers is 0.24 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $62,298,000 | +758.7% | 1,344,652 | +351.9% | 0.06% | +685.7% |
| Q1 2019 | $7,255,000 | -56.8% | 297,568 | -70.6% | 0.01% | -22.2% |
| Q2 2018 | $16,786,000 | +117.5% | 1,013,304 | +114.3% | 0.01% | +12.5% |
| Q1 2018 | $7,719,000 | -15.4% | 472,952 | -33.6% | 0.01% | -20.0% |
| Q4 2017 | $9,122,000 | +10.0% | 712,671 | -28.0% | 0.01% | -9.1% |
| Q2 2017 | $8,290,000 | +189.4% | 990,441 | +133.3% | 0.01% | +120.0% |
| Q3 2016 | $2,865,000 | +4521.0% | 424,452 | +2332.1% | 0.01% | – |
| Q2 2016 | $62,000 | -99.0% | 17,452 | -99.2% | 0.00% | -100.0% |
| Q1 2016 | $6,356,000 | -53.1% | 2,154,652 | -32.9% | 0.01% | -60.0% |
| Q4 2015 | $13,548,000 | +219.7% | 3,210,394 | +245.4% | 0.03% | +200.0% |
| Q3 2015 | $4,238,000 | -27.6% | 929,428 | +14.5% | 0.01% | -23.1% |
| Q2 2015 | $5,854,000 | -24.7% | 811,995 | -23.0% | 0.01% | -23.5% |
| Q1 2015 | $7,773,000 | +14566.0% | 1,054,652 | +7001.1% | 0.02% | – |
| Q3 2014 | $53,000 | -97.1% | 14,852 | -95.9% | 0.00% | -100.0% |
| Q4 2013 | $1,823,000 | -50.1% | 363,852 | -38.0% | 0.00% | -55.6% |
| Q3 2013 | $3,650,000 | – | 586,752 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|